BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31126212)

  • 1. Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus.
    Grinnell M; Bath A; DiMaio D; Hultgren T; Hearth-Holmes M
    Lupus; 2019 Jul; 28(8):1013-1016. PubMed ID: 31126212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
    Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
    Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
    Kozlovskaia NL; Kabaenkova GS; Varshavskiĭ VA; Shvetsov MIu
    Klin Med (Mosk); 1995; 73(3):93-6. PubMed ID: 8577127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculitis in antiphospholipid syndrome.
    Lally L; Sammaritano LR
    Rheum Dis Clin North Am; 2015; 41(1):109-23, ix. PubMed ID: 25399943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome in systemic lupus erythematosus.
    Hill GS; Nochy D
    J Am Soc Nephrol; 2007 Sep; 18(9):2461-4. PubMed ID: 17699810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus, hypercoagulable states, and antiphospholipid antibodies.
    Roubey RA
    Arthritis Care Res; 1999 Jun; 12(3):155-6. PubMed ID: 10513504
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.
    Nagata H; Sato M; Ogura M; Yoshikawa T; Yamamoto K; Matsumura S; Kano Y; Saida K; Sako M; Kamei K; Yoshioka T; Ogata K; Ito S; Ishikura K
    Nephrology (Carlton); 2018 Jun; 23(6):592-596. PubMed ID: 28976051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis in systemic lupus erythematosus: the role of antiphospholipid antibody.
    Qushmaq K; Esdaile J; Devine DV
    Arthritis Care Res; 1999 Jun; 12(3):212-9. PubMed ID: 10513512
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombosis in systemic lupus erythematosus: risk and protection.
    Burgos PI; Alarcón GS
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1541-9. PubMed ID: 19954316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
    Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
    Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Lupus Erythematosus and Antiphospholipid Syndrome-The Double Trouble.
    Londhey V
    J Assoc Physicians India; 2017 Mar; 65(3):11-12. PubMed ID: 28462537
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
    Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
    Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal vascular complications of systemic lupus erythematosus.
    Appel GB; Pirani CL; D'Agati V
    J Am Soc Nephrol; 1994 Feb; 4(8):1499-515. PubMed ID: 8025223
    [No Abstract]   [Full Text] [Related]  

  • 15. Catastrophic antiphospholipid syndrome presented as ruptured papillary muscle during puerperium in a patient with systemic lupus erythematosus.
    Rato IR; Barbosa AR; Afonso DJ; Beça S
    Lupus; 2021 May; 30(6):1017-1021. PubMed ID: 33736518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livedo racemosa and thrombotic vasculitides of scalp in systemic lupus erythematosus.
    Lee JY; Tsai CY; Liao HT
    Ann Rheum Dis; 2022 Oct; 81(10):1474. PubMed ID: 35788495
    [No Abstract]   [Full Text] [Related]  

  • 17. Livedoid vasculopathy: thrombotic or inflammatory disease?
    Khenifer S; Thomas L; Balme B; Dalle S
    Clin Exp Dermatol; 2010 Oct; 35(7):693-8. PubMed ID: 19874344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis.
    Moroni G; Ventura D; Riva P; Panzeri P; Quaglini S; Banfi G; Simonini P; Bader R; Meroni PL; Ponticelli C
    Am J Kidney Dis; 2004 Jan; 43(1):28-36. PubMed ID: 14712424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial thrombosis in systemic lupus erythematosus.
    Sabio JM; Jiménez-Alonso J
    N Engl J Med; 2004 Oct; 351(18):1910-1; author reply 1910-1. PubMed ID: 15509829
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Hawro T; Maurer M; Sysa-Jędrzejowska A; Woźniacka A
    Br J Dermatol; 2013 Jan; 168(1):213-5. PubMed ID: 22646136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.